Clinical Trial Update: Safety and Pregnancy Outcomes in Thrombocythemia Patients Exposed to XAGRID® (Anagrelide Hydrochloride) Compared to Other Treatments

View source ↗

Summary

Clinical trial update reporting safety and pregnancy outcomes in thrombocythemia patients exposed to XAGRID compared with other treatments.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Thrombocythemia
• Thrombocythemia

Drugs mentioned

• XAGRID®

Snippet

Sponsor: Shire | Conditions: Thrombocythemia, Essential | Status: COMPLETED | Results posted: 2015-11-17